KIMBERLY CLARK CORP News
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. In addition, it sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. The company was founded in 1872 and is headquartered in Dallas, Texas.
see moreKIMBERLY CLARK CORP Market News
11min
Kimberly‑Clark Completes Acquisition of Kenvue, Settles $7 B Note Exchange
- Kimberly‑Clark (KMB) has completed its acquisition of Kenvue, finalized a $7 billion note exchange and expects $2.1 billion in run‑rate synergies.
11d
Kimberly‑Clark Prices $4.9 Billion Senior Notes to Support Kenvue Acquisition and Reports Preliminary Q3 Results
Kimberly‑Clark this week priced a $4.9 billion senior note offering to fund its pending Kenvue acquisition, alongside preliminary Q3 2026 results.
18d
Kimberly‑Clark Confirms Preliminary Q3 Results and Reaffirms 2026 Outlook Following SEC Filing
Kimberly‑Clark stock rose sharply after preliminary Q3 data beat estimates and the company reaffirmed its 2026 guidance, ahead of full earnings set for November 5.
25d
Piper Sandler Raises Price Target on Kimberly‑Clark Amid Mixed Q2 Results
Piper Sandler lifted its target to $121 on KMB following a Q2 earnings beat on adjusted EPS, despite weak organic growth and revised guidance.
03 Oct at 10:35
Kimberly‑Clark Launches $7 Billion Kenvue Note Exchange as Deal Progresses
Kimberly‑Clark has commenced a $7 billion exchange offer for Kenvue‑linked notes to advance its $40 billion acquisition strategy.